Summary & Overview
CPT 16029: Dermatologic Operative Procedure
CPT code 16029 denotes a dermatologic operative procedure (description listed as "16029") relevant to wound and skin surgical care. Nationally, procedural codes like this are used to classify surgical interventions for billing, reimbursement, quality measurement, and administrative tracking across payers. Accurate use of this CPT code affects claim adjudication, provider reimbursement, and aggregate utilization reporting.
Key payers covered in this review include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context for the procedure, expected sites of service, and which payers commonly process claims for this type of surgical dermatology service. The publication summarizes available benchmarks for utilization and reimbursement where available, highlights policy updates that affect coding and coverage, and outlines operational considerations for billing and documentation. Data elements not provided in the input (for example, specific modifiers, associated taxonomies, and ICD-10 pairings) are noted as unavailable.
This national-level summary is intended to inform health system administrators, billing professionals, and policy analysts about the role of CPT code 16029 in clinical billing frameworks, common payer coverage patterns, and the types of content readers can expect in the full publication.
Billing Code Overview
CPT code 16029 represents a procedure described as "16029." Based on the code description, the service is a surgical procedure involving wound management or skin-related operative care. The service type is surgical/operative dermatologic procedure. The typical site of service is an outpatient surgical setting such as an ambulatory surgery center or hospital outpatient department.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient scenario involves an adult or pediatric patient presenting for chemical peel application using a medium-depth or deep chemical agent applied to treat actinic keratoses, significant photodamage, dyspigmentation, acne scarring, or pre-malignant epidermal lesions. The procedure is performed in an ambulatory dermatology clinic, outpatient surgical center, or physician office. The clinical workflow includes pre-procedure evaluation (medical history, contraindications, informed consent), preparation of the treatment area (cleansing, degreasing, topical anesthesia or local nerve block if needed), sequential application of the chemical agent to achieve the desired depth of peel, neutralization (if applicable), post-procedure wound care instructions, and follow-up visits for monitoring re-epithelialization and managing complications such as infection or pigmentary change. Typical personnel participating include a board-certified dermatologist or plastic surgeon as the primary clinician, supporting licensed practical nurses or medical assistants for preparation and post-care, and front-office staff for scheduling and billing.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management (E/M) service by the same physician on the day of a procedure | Use when a distinct E/M visit is performed and documented on the same day as the chemical peel |